Papillary renal cell carcinoma: Quantitation of chromosomes 7 and 17 by FISH, analysis of chromosome 3p for LOH, and DNA ploidy

Diagnostic Molecular Pathology

Volumn 5, Issue 1, 1996, Pages 53-64

  Corless, Christopher L ^d   Aburatani, Hiroyuki ^b   Fletcher, Jonathan A ^a   Housman, David E ^b   Amin, Mahul B ^c   Weinberg, David S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c HENRY FORD HOSPITAL   (United States)

^d PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Chromosome 17; Chromosome 3; Chromosome 7; Cytogenetics; DNA ploidy; FISH; Flow cytometry; Loss of heterozygosity; Papillary renal cell carcinoma; Renal neoplasms

Indexed keywords

ARTICLE; CHROMOSOME 17; CHROMOSOME 3P; CHROMOSOME 7; CYTOGENETICS; DNA DETERMINATION; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; HETEROZYGOSITY; HUMAN; HUMAN CELL; KARYOTYPE; KIDNEY CANCER; PLOIDY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADULT; AGED; CARCINOMA, RENAL CELL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 7; FEMALE; HETEROZYGOTE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PLOIDIES;

EID: 0030027790     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-199603000-00009     Document Type: Article

References (53)

1. Aly MS, Cin PD, Van de Woude W, et al. Chromosome abnormalities in benign prostatic hyperplasia. Genes Chromosom Cancer 1994;9:227-33.
2. American Joint Committee on Cancer. Manual for staging of cancer. 4th ed. Philadelphia: Lippincott, 1993.
3. Anglard P, Tory K, Brauch H, et al. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma. Cancer Res 1991;51:1071-77.
4. Bandyk MG, Zhao L, Troncoso P, et al. Trisomy 7: a potential cytogenetic marker of human prostate cancer progression. Genes Chromosom Cancer 1994;9:19-27.
5. Boczko S, Fromowitz FB, Bard RH. Papillary adenocarcinoma of the kidney. A new perspective. Urology 1979;14: 491-5.
6. Brooks JD, Bova GS, Marshall FF, Isaacs WB. Tumor suppressor gene allelic loss in human renal cancers. J Urol 1993; 150:1278-83.
7. Casalone R, Casalone PG, Minelli E, et al. Significance of the clonal and sporadic chromosome abnormalities in nonneoplastic renal tissue. Hum Genet 1992;90:71-8.
8. Dal Cin P, Li FP, Prout Jr GR, et al. Involvement of chromosomes 3 and 5 in renal cell carcinoma. Cancer Genet Cytogenet 1988;35:41-6.
9. Dal Cin P, Gaeta J, Huben R, Li FP, Prout GR, Sandberg AA. Renal cortical tumors: cytogenetic characterization. Am J Clin Pathol 1989;92:408-14.
10. El-Naggar AK, Batsakis JG, Wang G, Lee M-S. PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms. Diag Mol Pathol 1993;2:269-76.
11. El-Naggar AK, Ro JY, Ensign LG. Papillary renal cell car- cinoma: clinical implication of DNA content analysis. Hum Pathol 1993;24:316-21.
12. Emanuel A, Szucs S, Weier HU, Kovacs G. Clonal aberrations of chromosomes X, Y, 7 and 10 in normal kidney tissue of patients with renal cell tumors. Genes Chromosom Cancer 1992;4:75-7.
13. Farnsworth WV, Cohen C, McCue PA, DeRose PB. DNA analysis of small renal cortical neoplasms. Comparison with renal carcinomas. J Urol Pathol 1994;2:65-79.
14. Fleming S. The impact of genetics on the classification of renal carcinoma. Histopathology 1993;22:89-92.
15. Fletcher JA, Kozakewich HP, Hoffer FA, et al. Diagnostic relevance of clonal cytogenetic aberrations in malignant soft tissue tumors. N Engl J Med 1991;324:436-43.
16. Fromowitz FB, Bard RH. Clinical implications of pathologic subtypes in renal cell carcinoma. Semin Urol 1990;8:31-50.
17. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655-63.
18. Gnarra JR, Glenn GM, Latif F, et al. Molecular genetic studies of sporadic and familial renal cell carcinoma. Urol Clin North Am 1993;20:207-16.
19. Gnarra JR, Tory K, Weng Y, et al. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 1994; 7:85-90.
20. Goelz SE, Hamilton SR, Vogelstein B. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun 1985;130:118-26.
21. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983;31:1333-5.
22. Henn W, Zwergel T, Wullich B, Thonnes M, Zang KD, Seitz G. Bilateral multicentric papillary renal tumors with heteroclonal origin based on tissue-specific karyotype instability. Cancer 1993;72:1315-8.
23. Hopman AH, Moesker O, Smeets AW, Pauwels RP, Vooijs GP, Ramaekers FC. Numerical chromosome 1, 7, 9 and 11 aberrations in bladder cancer detected by in situ hybridization. Cancer Res 1991;51:644-51.
24. Hudson TJ, Engelstein M, Lee MK, et al. Isolation and chromosomal assignment of 100 highly informative human simple sequence repeat polymorphisms. Genomics 1992;13: 622-9.
25. Hughson MD, Johnson LD, Silva FG, Kovacs G. Nonpapillary and papillary renal cell carcinoma: a cytogenetic and phenotypic study. Mod Pathol 1993;6:449-56.
26. Ishikawa I, Kovacs G. High incidence of papillary renal cell tumours in patients on chronic haemodialysis. Histopathology 1993;22:135-9.
27. Ishikawa I, Shikura N, Ozaki M. Papillary renal cell carcinoma with numeric changes of chromosomes in a long-term hemodialysis patient: a karyotype analysis. Am J Kidney Dis 1993;21:553-6.
28. Johansson B, Heim S, Mandahl N, Mertens F, Mitelman F. Trisomy 7 in nonneoplastic cells. Genes Chromosom Cancer 1993;6:199-205.
29. Jones MH, Yamakawa K, Nakamura Y. Isolation and characterization of 19 dinucleotide repeat polymorphisms on chromosome 3p. Hum Mol Genet 1992;1:131-3.
30. Kovacs G. Papillary renal cell carcinoma. A morphologic and cytogenetic study of 11 cases. Am J Pathol 1989;134: 27-34.
31. Kovacs G. Molecular differential pathology of renal cell tumours. Histopathology 1993;22:1-8.
32. Kovacs G, Kovacs A. Parenchymal abnormalities associated with papillary renal cell tumors: a morphologic study. J Urol Pathol 1993;1:301-12.
33. Kovacs G, Erlandsson R, Boldog F, et al. Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. Proc Natl Acad Sci USA 1988;85:1571-5.
34. Kovacs G, Fuzesi L, Emanual A, Kung HF. Cytogenetics of papillary renal cell tumors. Genes Chromosom Cancer 1991; 3:249-55.
35. Li FP, Decker H-J, Zbar B, et al. Clinical and genetic studies of renal cell carcinomas in a family with a constitutional chromosome 3;8 translocation. Ann Intern Med 1993;118: 106-11.
36. Limon J, Dal Cin P, Sandberg AA. Application of long-term collagenase disaggregation for the cytogenetic analysis of human solid tumors. Cancer Genet Cytogenet 1986;23:305-17.
37. Ljungberg B, Nordenson I, Roos G. Cytogenetic and flow cytometric DNA analysis in renal cell carcinoma. Eur Urol 1991;19:59-64.
38. Mancilla-Jimenez R, Stanley RJ, Blath RA. Papillary renal cell carcinoma. A clinical, radiologic, and pathologic study of 34 cases. Cancer 1976;38:2469-80.
39. Meloni AM, Bridge J, Sandberg AA. Reviews on chromosome studies in urological tumors. I. Renal Tumors. J Urol 1992;148:253-65.
40. Morita R, Ishikawa J, Tsutsumi M, et al. Allelotype of renal cell carcinoma. Cancer Res 1991;51:820-3.
41. Mydlo JH, Bard RH. Analysis of papillary renal adenocarcinoma. Urology 1987;30:529-34.
42. Presti Jr JC, Rao PH, Chen Q, et al. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. Cancer Res 1991;51:1544-52.
43. Presti JC, Reuter VE, Cordon-Cardo C, Mazumdar M, Fair WR, Jhanwar SC. Allelic deletions in renal tumors: histopathological correlations. Cancer Res 1993;53:5780-3.
44. Renshaw AR, Corless CL. Papillary renal cell carcinoma: histology and immunohistochemistry. Am J Surg Pathol 1995;19:842-9.
45. Schofield DE, Yunis EJ, Fletcher JA. Chromosome aberrations in mesoblastic nephroma. Am J Pathol 1993;143:714-24.
46. Schofield DE, Fletcher JA, Holcombe EG, Yunis EJ. Fibrosarcoma in infants and children. Application of new techniques. Am J Surg Pathol 1994;18:14-24.
47. Seabright M. A rapid banding technique for human chromosomes. Lancet 1971;2:971-2.
48. Takahashi S, Qian J, Brown JA, et al. Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. Cancer Res 1994;54: 3574-9.
49. Van den Berg E, van der Hout AH, Oosterhuis JW, et al. Cytogenetic analysis of epithelial renal-cell tumours: relationship with a new histopathological classification. Int J Cancer 1993;55:223-7.
50. Van der Hout AH, van den Berg E, van der Vlies P, et al. Loss of heterozygosity at the short arm of chromosome 3 in renal-cell cancer correlates with the cytological tumour type. Int J Cancer 1993;53:353-7.
51. Voravud N, Shin DM, Ro JY, Lee JS, Hong WK, Hittelman WN. Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis. Cancer Res 1993; 53:2874-83.
52. Waldman FM, Carroll PR, Kerschmann R, Cohen MB, Field FG, Mayall BH. Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer. Cancer Res 1991;51:3807-13.
53. Zbar B, Tory K, Merino M, et al. Hereditary papillary renal cell carcinoma. J Urol 1994;151:561-6.